Tech
Deciphex, an Irish company that develops software to accelerate the delivery of pathology services, has raised $11.5 million from backers that include pharma giant Novartis and contact research organisation Charles River Laboratories. Dublin-based Act Venture Capital led the latest financing which brings total funding to date for Deciphex to $19.5 million. Other participants in the Series B found include Irrus Investments, Nextsteps Capital and the HBAN Medtech Syndicate.